Literature DB >> 193792

Antibody-dependent cellular protection against herpes simplex virus dissemination as revealed by viral plauqe and infectivity assays.

F Shimizu, K Hanaumi, Y Shimizu, K Kumagai.   

Abstract

Mouse nonimmune peripheral blood lymphocytes (PBL) plus antibody to herpes simplex virus inhibited virus dissemination in herpes simplex virus-infected 3T3 cell culture as revealed by development of viral plaque, size of immunofluorescent foci, appearance of polycaryocytes, and viral infectivity appearing in the culture. These nonimmune PBL did not act alone in inibiting virus dissemination, but did act synergistically in combination with antibody. The ratio of PBL to target monolayer cells needed to produce this effect was 20. Splenic lymphocytes had weak activity, whereas thymocytes were without effect, even in the presence of antibody. Neither interferon nor lymphotoxin was detected in this lymphocyte-mediated response. These findings support previous observations, based on cytotoxicity assays, that antibody-dependent cellular immune processes could be important in control of and recovery from herpesvirus infection.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193792      PMCID: PMC420987          DOI: 10.1128/iai.16.2.531-536.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Lysis of herpesvirus-infected cells by immune spleen cells.

Authors:  I A Ramshaw
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

2.  Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.

Authors:  S L Shore; C M Black; F M Melewicz; P A Wood; A J Nahmias
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

3.  The role of antibody dependent cytotoxicity in recovery from herpesvirus infections.

Authors:  B T Rouse; R C Wardley; L A Babiuk
Journal:  Cell Immunol       Date:  1976-03-01       Impact factor: 4.868

4.  Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.

Authors:  A S Russell; J S Percy; T Kovithavongs
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

5.  Specific inactivation of herpes simplex virus by silver nitrate at low concentrations and biological activities of the inactivated virus.

Authors:  F Shimizu; Y Shimizu; K Kumagai
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

6.  Immune destruction of virus-infected cells early in the infectious cycle.

Authors:  S L Shore; T L Cromeans; T J Romano
Journal:  Nature       Date:  1976-08-19       Impact factor: 49.962

7.  Studies of surface immunoglobulins on human B lymphocytes. I. Dissociation of cell-bound immunoglobulins with acid pH or at 37 degrees C.

Authors:  K Kumagai; T Abo; T Sekizawa; M Sasaki
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

8.  Studies of surface immunoglobulins on human B lymphocytes. II. Characterization of a population of lymphocytes lacking surface immunoglobulins but carrying Fc receptor (SIg-Fc+ cell).

Authors:  T Abo; T Yamaguchi; F Shimizu; K Kumagai
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

9.  Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell.

Authors:  G Trinchieri; P Bauman; M De Marchi; Z Tökés
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

10.  Host defense mechanisms against Herpes simplex virus. I. Control of infection in vitro by senstized spleen cells and antibody.

Authors:  F A Ennis
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

View more
  6 in total

1.  Suppression of in vitro growth of virulent and avirulent herpes simplex viruses by cell-mediated immune mechanisms, antibody, and interferon.

Authors:  F Shimizu; J Satoh; M Tada; K Kumagai
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

2.  Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.

Authors:  N Balachandran; S Bacchetti; W E Rawls
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

3.  Role of antibody in primary and recurrent herpes simplex virus infection.

Authors:  A Simmons; A A Nash
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

4.  Analysis of the adhesion step in the herpes simplex virus antibody-dependent cellular cytotoxicity system.

Authors:  T J Romano; S L Shore
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

5.  Relationship of antibody to outcome in neonatal herpes simplex virus infections.

Authors:  A S Yeager; A M Arvin; L J Urbani; J A Kemp
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

6.  Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

Authors:  Tamara P Blevins; Michelle C Mitchell; Maria Korom; Hong Wang; Yinyi Yu; Lynda A Morrison; Robert B Belshe
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.